Abstract MicroRNA‑223 (miR‑223) is dysregulated in various cancer types, including acute
myeloid leukemia (AML). Despite this, there has been a lack of studies exploring the role of …

Acute myeloid leukemia (AML) is a heterogeneous malignant disorder derived from the
myeloid hematopoietic cells that accounts for~ 80% of all adult acute leukemia. Numerous …

Many microRNAs (miRNAs) are evolutionarily conserved and have intriguing expression
patterns. Tissue and/or time-specific expressions of some miRNAs are presumably …

The expression of microRNA-223 (miR-233) has been investigated in various types of
cancer. However, to the best of our knowledge, the expression and function of miR-223 in …

MicroRNAs (miRNAs) constitute a large family of small, non-coding RNAs with the capacity
to regulate gene expression post-transcriptionally. miRNAs appear to hold promise of …

The relapse and resistance to cytarabine (Ara-C) therapy is still a dominating obstacle to the
successful clinical treatment of acute myeloid leukemia (AML). Recent studies have shown …

Background Identification of biomarkers for acute myeloid leukemia (AML) is important for
treating this malignancy. Recent studies have reported that microRNAs (miRNAs) are stably …

MicroRNAs (miRNAs) are thought to modulate a variety of cellular events. Several studies
have revealed the functions of miR‐223 in granulopoiesis. Here we analysed miR‐223 …

Abstract microRNA‑125b (miR‑125b) is overexpressed in several types of cancer and
contributes to tumor resistance to chemotherapy. The present study investigated the effect of …

Introduction: Chronic myeloid leukaemia (CML) is a myeloproliferative neoplasm
characterized by constitutive activity of the tyrosine kinase BCR-ABL1. Drug resistance …